文献速递肥胖与代谢综合征糖尿病

减重手术后脂肪体脂质组变化与体重下降及心血管代谢获益相关

Adiposome Lipidomic Shifts Following Bariatric Surgery in Association With Weight Loss and Cardiometabolic Benefit.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

术后BMI、内脏脂肪、HOMA-IR、炎症标志物及收缩压显著下降,血管功能改善;脂肪体脂质组发生重塑,部分脂质变化与BMI变化及一氧化氮、血管反应性、脂联素改善相关,机器学习模型可高精度预测BMI。

要点

  • 减重手术可重塑脂肪体脂质组,脂质类别层面呈甘油三酯、甘油二酯、胆固醇酯、磷脂酸、脂肪酸及酰基肉碱下降。
  • 术后磷脂酰胆碱、磷脂酰乙醇胺、溶血磷脂酰胆碱、鞘磷脂、超长链神经酰胺及FAHFAs升高,BMI降幅≥20%者变化更大。
  • 36种脂质变化与BMI变化相关,部分脂质与一氧化氮、血管反应性及脂联素改善同步。

核心结论

  • 减重手术可重塑脂肪体脂质组,且这些脂质变化与心血管代谢风险标志物改善相一致。

主要发现

  • 减重手术后BMI、内脏脂肪、HOMA-IR、炎症标志物及收缩压显著下降,血管功能明显改善。
  • 脂肪体脂质组共鉴定19类550种脂质,术后124种升高、66种降低。
  • 类水平上甘油三酯、甘油二酯、胆固醇酯、磷脂酸、脂肪酸及酰基肉碱下降,磷脂酰胆碱、磷脂酰乙醇胺、溶血磷脂酰胆碱、鞘磷脂、超长链神经酰胺及FAHFAs升高,BMI降幅≥20%者变化更大。
  • 36种脂质变化与BMI变化相关:甘油三酯18:1/20:4/22:6正相关,SM d40:1、SM d42:4及磷脂酰胆碱17:0/18:2负相关。
  • 一氧化氮、血管反应性及脂联素改善与超长链神经酰胺/FAHFAs/磷脂升高及酰基肉碱/胆固醇酯/甘油二酯/磷脂酸下降同步。

临床怎么用

  • 减重手术后脂肪体脂质组重塑与心血管代谢风险标志物改善同步,提示脂肪体脂质可作为评估代谢获益的候选标志物。
  • SM d40:1、SM d42:4及脂肪酸17:1在机器学习模型中为预测BMI的主要脂质特征,但尚需外部验证。
  • 脂质变化在BMI降幅≥20%者更明显,提示体重下降幅度可能与脂肪体脂质重塑程度相关。

局限性

  • 原文未报告研究设计类型、随访时长及混杂因素控制等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Adiposomes carry bioactive lipids that shape systemic metabolism and vascular function. OBJECTIVE: Building on our previous findings that obese adiposomes are ceramide/free fatty acid-enriched and linked to dysfunction, we tested whether bariatric surgery remodels adiposome lipidomes and whether these shifts track with metabolic and vascular improvements. METHODS: Twenty-three obese individuals were assessed before and after bariatric surgery. Clinical evaluations included body mass index (BMI), body composition, glycemic markers, inflammatory markers, and vascular function. Adipose tissue biopsies were collected, and adiposomes were isolated for non-targeted lipidomic analysis using mass spectrometry. RESULTS: Bariatric surgery induced significant reductions in BMI, visceral fat, HOMA-IR, inflammatory markers, and systolic blood pressure, alongside marked improvements in vascular function. Adiposome lipidomics identified 550 species across 19 classes; 124 increased and 66 decreased after surgery. Class-level shifts showed decreases in triglycerides, diglycerides, cholesteryl esters, phosphatidic acids, fatty acids, and acylcarnitines, with increases in phosphocholines, phosphoethanolamines, lysophosphatidylcholines, sphingomyelins, ultralong-chain ceramides, and fatty acid-hydroxy fatty acids (FAHFAs); these changes were larger in participants with ≥20% BMI reduction. Changes in 36 lipid species correlated with BMI change: triglycerides 18:1/20:4/22:6 positively, and sphingomyelins (SM) d40:1, SM d42:4, and phosphatidylcholine 17:0/18:2 inversely. Improvements in nitric oxide, vascular reactivity, and adiponectin tracked with rises in ultralong-chain ceramide/FAHFAs/phospholipids and declines in acylcarnitine/cholesterol esters/diacylglycerols/phosphatidic acids. Machine learning models predicted BMI from lipid features with >80% accuracy (R2 >0.90; mean absolute error <0.3), highlighting SM d40:1, SM d42:4, and fatty acid 17:1 as top contributors. Pathway enrichment analysis linked these changes to sphingolipid signaling and glycerophospholipid metabolism. CONCLUSION: Bariatric surgery remodels adiposome lipids, and these shifts align with improvements in cardiometabolic risk markers.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Metwally E, Burton L, Mirza I, et al. Adiposome Lipidomic Shifts Following Bariatric Surgery in Association With Weight Loss and Cardiometabolic Benefit. J Clin Endocrinol Metab. 2026. PMID: 41137449. doi:10.1210/clinem/dgaf586

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。